176 related articles for article (PubMed ID: 32496985)
1. New Perspectives in the Pharmacological Potential of Naringin in Medicine.
Rivoira MA; Rodriguez V; Talamoni G; Tolosa de Talamoni N
Curr Med Chem; 2021; 28(10):1987-2007. PubMed ID: 32496985
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
Yang Y; Trevethan M; Wang S; Zhao L
J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
Joshi R; Kulkarni YA; Wairkar S
Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
[TBL] [Abstract][Full Text] [Related]
4. PVP- coated naringenin nanoparticles for biomedical applications - In vivo toxicological evaluations.
Kumar RP; Abraham A
Chem Biol Interact; 2016 Sep; 257():110-8. PubMed ID: 27417253
[TBL] [Abstract][Full Text] [Related]
5. Naringin and Rutin Alleviates Episodic Memory Deficits in Two Differentially Challenged Object Recognition Tasks.
Ramalingayya GV; Nampoothiri M; Nayak PG; Kishore A; Shenoy RR; Mallikarjuna Rao C; Nandakumar K
Pharmacogn Mag; 2016 Jan; 12(Suppl 1):S63-70. PubMed ID: 27041861
[TBL] [Abstract][Full Text] [Related]
6. Naringin prevents bone damage in the experimental metabolic syndrome induced by a fructose-rich diet.
Rivoira MA; Rigalli A; Corball L; Tolosa de Talamoni N; Rodríguez V
Appl Physiol Nutr Metab; 2022 Apr; 47(4):395-404. PubMed ID: 34890288
[TBL] [Abstract][Full Text] [Related]
7. A narrative review on Naringin and Naringenin as a possible bioenhancer in various drug-delivery formulations.
Ganesh P; Suresh V; Narasimhan MK; Sabarathinam S
Ther Deliv; 2023 Dec; 14(12):763-774. PubMed ID: 38088094
[TBL] [Abstract][Full Text] [Related]
8. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of naringin on the micronuclei induced by ifosfamide in mouse, and evaluation of its modulatory effect on the Cyp3a subfamily.
Alvarez-González I; Madrigal-Bujaidar E; Dorado V; Espinosa-Aguirre JJ
Mutat Res; 2001 Sep; 480-481():171-8. PubMed ID: 11506811
[TBL] [Abstract][Full Text] [Related]
10. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
[TBL] [Abstract][Full Text] [Related]
11. The Intestinal Fate of Citrus Flavanones and Their Effects on Gastrointestinal Health.
Stevens Y; Rymenant EV; Grootaert C; Camp JV; Possemiers S; Masclee A; Jonkers D
Nutrients; 2019 Jun; 11(7):. PubMed ID: 31252646
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of naringenin in the stomach and colon using liquid chromatography/electrospray ionization linear ion trap quadrupole-Orbitrap-mass spectrometry (LC-ESI-LTQ-Orbitrap-MS) and LC-ESI-MS/MS.
Orrego-Lagarón N; Vallverdú-Queralt A; Martínez-Huélamo M; Lamuela-Raventos RM; Escribano-Ferrer E
J Pharm Biomed Anal; 2016 Feb; 120():38-45. PubMed ID: 26698229
[TBL] [Abstract][Full Text] [Related]
13. Simultaneously Quantitative Analysis of Naringin and Its Major Human Gut Microbial Metabolites Naringenin and 3-(4'-Hydroxyphenyl) Propanoic Acid via Stable Isotope Deuterium-Labeling Coupled with RRLC-MS/MS Method.
Chen T; Wu H; He Y; Pan W; Yan Z; Liao Y; Peng W; Gan L; Zhang Y; Su W; Yao H
Molecules; 2019 Nov; 24(23):. PubMed ID: 31775267
[TBL] [Abstract][Full Text] [Related]
14. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
[TBL] [Abstract][Full Text] [Related]
15. The Therapeutic Potential of Naringenin: A Review of Clinical Trials.
Salehi B; Fokou PVT; Sharifi-Rad M; Zucca P; Pezzani R; Martins N; Sharifi-Rad J
Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30634637
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of two citrus flavanones on bone quality in senescent male rats in relation to their bioavailability and metabolism.
Habauzit V; Sacco SM; Gil-Izquierdo A; Trzeciakiewicz A; Morand C; Barron D; Pinaud S; Offord E; Horcajada MN
Bone; 2011 Nov; 49(5):1108-16. PubMed ID: 21820093
[TBL] [Abstract][Full Text] [Related]
17. Naringin alleviates methotrexate-induced liver injury in male albino rats and enhances its antitumor efficacy in HepG2 cells.
Elsawy H; Algefare AI; Alfwuaires M; Khalil M; Elmenshawy OM; Sedky A; Abdel-Moneim AM
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32458964
[TBL] [Abstract][Full Text] [Related]
18. Nanocomplexes based polyvinylpyrrolidone K-17PF for ocular drug delivery of naringenin.
Wang H; Li X; Yang H; Wang J; Li Q; Qu R; Wu X
Int J Pharm; 2020 Mar; 578():119133. PubMed ID: 32057887
[TBL] [Abstract][Full Text] [Related]
19. The fate of naringin in humans: a key to grapefruit juice-drug interactions?
Fuhr U; Kummert AL
Clin Pharmacol Ther; 1995 Oct; 58(4):365-73. PubMed ID: 7586927
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of naringin against the LPS-induced apoptosis of PC12 cells: Implications for the treatment of neurodegenerative disorders.
Wang H; Xu YS; Wang ML; Cheng C; Bian R; Yuan H; Wang Y; Guo T; Zhu LL; Zhou H
Int J Mol Med; 2017 Apr; 39(4):819-830. PubMed ID: 28260042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
